Alim Ladha, Ph.D.
Dr. Alim Ladha is responsible for investment identification, due diligence, business development, and company creation activities at MPM and BioImpact Capital, an affiliate manager of MPM.
Prior to joining MPM and BioImpact Capital, Alim completed his Ph.D. in Biological Engineering at the Massachusetts Institute of Technology (MIT) in Feng Zhang’s lab at the Broad Institute where he focused on developing new molecular tools for biotechnology including CRISPR-associated transposases, retroelement based genome insertion methods, novel nucleic acid delivery vehicles, and CRISPR-based diagnostics. Prior to MIT, Alim worked on the development of microbiome-based therapeutics at Finch Therapeutics and OpenBiome.
Alim received his B.S.E., summa cum laude, in Biomedical Engineering from Duke University.